Christa E. Müller
Christa E. Müller
Verified email at uni-bonn.de - Homepage
Title
Cited by
Cited by
Year
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update
BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller
Pharmacological reviews 63 (1), 1-34, 2011
11942011
Recent developments in adenosine receptor ligands and their potential as novel drugs
CE Müller, KA Jacobson
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1290-1308, 2011
3962011
Structure of the human P2Y 12 receptor in complex with an antithrombotic drug
K Zhang, J Zhang, ZG Gao, D Zhang, L Zhu, GW Han, SM Moss, ...
Nature 509 (7498), 115-118, 2014
3202014
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors
T Gnad, S Scheibler, I von Kügelgen, C Scheele, A Kilić, A Glöde, ...
Nature 516 (7531), 395-399, 2014
2622014
Striatal adenosine A 2A and cannabinoid CB 1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids
P Carriba, O Ortiz, K Patkar, Z Justinova, J Stroik, A Themann, C Müller, ...
Neuropsychopharmacology 32 (11), 2249-2259, 2007
2612007
Agonist-bound structure of the human P2Y12 receptor
J Zhang, K Zhang, ZG Gao, S Paoletta, D Zhang, GW Han, T Li, L Ma, ...
Nature 509 (7498), 119-122, 2014
2562014
CD39/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
X Sun, Y Wu, W Gao, K Enjyoji, E Csizmadia, CE Müller, T Murakami, ...
Gastroenterology 139 (3), 1030-1040, 2010
2152010
CLINICAL PERSPECTIVE
D Köhler, T Eckle, M Faigle, A Grenz, M Mittelbronn, S Laucher, ML Hart, ...
Circulation 116 (16), 1784-1794, 2007
2062007
Involvement of adenosine A 1 and A 2A receptors in the motor effects of caffeine after its acute and chronic administration
M Karcz-Kubicha, K Antoniou, A Terasmaa, D Quarta, M Solinas, ...
Neuropsychopharmacology 28 (7), 1281-1291, 2003
2022003
Medicinal chemistry of adenosine, P2Y and P2X receptors
KA Jacobson, CE Müller
Neuropharmacology 104, 31-49, 2016
1972016
Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)
A Pick, H Müller, R Mayer, B Haenisch, IK Pajeva, M Weigt, H Bönisch, ...
Bioorganic & medicinal chemistry 19 (6), 2090-2102, 2011
1962011
The experimental power of FR900359 to study Gq-regulated biological processes
R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ...
Nature communications 6 (1), 1-17, 2015
1952015
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists
R Sauer, J Maurinsh, U Reith, F Fülle, KN Klotz, CE Müller
Journal of medicinal chemistry 43 (3), 440-448, 2000
1932000
Prodrug approaches for enhancing the bioavailability of drugs with low solubility
CE Mueller
Chemistry & Biodiversity 6 (11), 2071-2083, 2009
1912009
Lignans Isolated from Valerian:  Identification and Characterization of a New Olivil Derivative with Partial Agonistic Activity at A1 Adenosine Receptors
B Schumacher, S Scholle, J Hölzl, N Khudeir, S Hess, CE Müller
Journal of Natural Products 65 (10), 1479-1485, 2002
1862002
Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress
MP Kaster, NJ Machado, HB Silva, A Nunes, AP Ardais, M Santana, ...
Proceedings of the National Academy of Sciences 112 (25), 7833-7838, 2015
1782015
Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor
ZG Gao, A Chen, D Barak, SK Kim, CE Müller, KA Jacobson
Journal of Biological Chemistry 277 (21), 19056-19063, 2002
1762002
Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors
CE Müller, J Iqbal, Y Baqi, H Zimmermann, A Röllich, H Stephan
Bioorganic & medicinal chemistry letters 16 (23), 5943-5947, 2006
1732006
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
MT Armentero, A Pinna, S Ferré, JL Lanciego, CE Müller, R Franco
Pharmacology & therapeutics 132 (3), 280-299, 2011
1722011
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
D Marcellino, P Carriba, M Filip, A Borgkvist, M Frankowska, I Bellido, ...
Neuropharmacology 54 (5), 815-823, 2008
1682008
The system can't perform the operation now. Try again later.
Articles 1–20